ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1354	National Cancer Institute	Html	null	Melanoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of melanoma.			CLICK HERE
1379	National Cancer Institute	Html	en	Cervical Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may increase the risk of developing cervical cancer and about approaches that may help in the prevention of this disease.	normal cervical cytology 0.510493 vaccine-treated women 0.487201 HPV types 0.757372 vaccine efficacy 0.741841 9-valent VLP vaccine 0.591937 vaccine-related HPV types 0.575946 prophylactic HPV vaccine 0.687205 HPV DNA testing 0.579437 vaccine efficacy rate 0.600644 persistent infection 0.526745 VLP vaccine 0.652393 HPV titers 0.562213 L1/2 HPV vaccines 0.566712 HPV type vs 0.562578 HPV-16/HPV-18 VLP vaccine 0.605344 pre-existing HPV infection 0.589015 cervical HPV DNA 0.601237 cervical cancers 0.492563 HPV-16/18 vaccine 0.555263 cervical cancer 0.587492 Rica Vaccine Trial 0.588987 nonvalent HPV vaccine. 0.569038 persistent HPV 0.541143 L1 VLP vaccine 0.61267	oncogenic HPV types 0.60386 two-dose schedule 0.501418 women 0.610755 9-valent HPV vaccine 0.681373 study 0.489719 HPV vaccination 0.541014 fully vaccinated women 0.493555 similar vaccine efficacy 0.608995 qHPV vaccine 0.557165 HPV vaccine 0.814126 true vaccine efficacy 0.62572 new vaccine 0.558251 12-month persistent infection 0.491511 invasive cervical cancer 0.57017 HPV infection offer 0.625011 common HPV types 0.578468 Vaccine efficacy rates 0.60682 9vHPV vaccine group 0.59158 bivalent HPV vaccine 0.686822 HPV infection 0.632752 vaccine 0.940033 placebo-controlled trial 0.490062 international randomized trial 0.490281 oncogenic types 0.491299	CLICK HERE
1399	National Cancer Institute	Html	en	Nausea and Vomiting Related to Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about nausea and vomiting as complications of cancer or its treatment. Approaches to the management of nausea and vomiting are discussed.	cancer treatment 0.379171 chemotherapy session 0.416704 past chemotherapy treatments 0.404595 motion sickness 0.3776 chemotherapy 0.552867 PDQ cancer information 0.463652 chemotherapy treatment 0.441369 late nausea 0.506038 anticipatory nausea 0.711385 clinical trials 0.378644 vomiting 0.900093 Vomiting Related 0.471509 cancer information summary 0.41736 patients 0.393418 earlier chemotherapy session 0.400031 treatment room 0.360635 NCI’s PDQ 0.353745 nausea 0.98576 NCI PDQ cancer 0.3835 radiation therapy 0.495467 antinausea drugs 0.406187 involuntary body functions 0.353798 certain chemotherapy drugs 0.416814 following treatment factors 0.366128	radiation therapy treatments 0.356798 treatment 0.558325 gastrointestinal tract 0.416866 following table 0.366172 delayed nausea 0.530808 Cancer Information Service 0.360675 following patient factors 0.352013 previous chemotherapy sessions 0.394908 patient 0.370352 treatment clinical trials 0.357831 National Cancer Institute 0.420163 Palliative Care Editorial 0.381728 new treatment 0.358991 chronic nausea 0.490418 drugs 0.426328 Cancer Care page 0.352418 Care Editorial Board 0.382615 chemotherapy sessions 0.400414 PDQ summary 0.40058 Nausea section 0.481663 cancer information summaries 0.360345 comprehensive cancer information 0.360198 cancer therapy 0.357442 acute nausea 0.484601	CLICK HERE
1430	National Cancer Institute	Html	en	Stomach (Gastric) Cancer Prevention (PDQ®)–Patient Version	Smoking and H. pylori infection are important risk factors for stomach (gastric) cancer. Learn about all of the risk factors for stomach cancer and how to prevent stomach cancer in this expert-reviewed summary.	PDQ Screening 0.364501 cancer risk factors 0.420087 cancer treatment 0.365273 Cancer prevention 0.532051 cancer prevention trials 0.402318 healthy diet 0.359621 cancer protective factor 0.402244 United States 0.45543 prevention clinical trials 0.399973 protective factors 0.416286 antibiotics lowers 0.358249 following PDQ summaries 0.402867 Cancer Information Service 0.393528 PDQ cancer information 0.513502 number 0.358741 Clinical Trials section 0.366407 common cancer 0.369836 Prevention Editorial Board 0.402679 treatment clinical trials 0.365364 dietary supplements 0.383267 H. pylori bacteria 0.36065 National Cancer Institute 0.462669 clinical trials 0.512934	PDQ documents 0.365522 beta carotene 0.388269 health care 0.357632 cancer information summary 0.455266 cancer doctors 0.360396 new treatment 0.364974 breast cancer prevention 0.387351 cancer patients 0.36264 Cancer Care page 0.385527 PDQ database 0.368612 latest published information 0.364412 cancer risk factor 0.42115 NCI’s PDQ 0.372914 PDQ summary 0.382762 NCI PDQ cancer 0.429445 cancer clinical trials 0.401358 stomach cancer 0.900678 risk factors 0.486241 cancer information summaries 0.399032 comprehensive cancer information 0.399493 stomach cancer prevention 0.492255 risk 0.486594	CLICK HERE
1596	National Cancer Institute	Html	en	Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of extragonadal germ cell tumors.	malignant extragonadal germ 0.298746 malignant tumor cells 0.298137 cancer treatment 0.292355 Cell Tumors Treatment 0.262583 cancer spreads 0.256757 body 0.292404 germ cell tumor 0.536364 following PDQ summaries 0.254729 PDQ cancer information 0.314684 clinical trial search 0.300526 clinical trials 0.586387 blood levels 0.251953 cancer information summary 0.288819 Benign extragonadal germ 0.279683 clinical trial 0.399211 good prognosis group 0.254652 stem cell transplant 0.261231 tumor markers 0.32423 patients 0.268211 treatment clinical trial 0.259833 PDQ Adult Treatment 0.25471 NCI PDQ cancer 0.263605 extragonadal germ cell 0.973537 radiation therapy 0.307388 Treatment Editorial Board 0.266625	poor prognosis group 0.253054 seminoma extragonadal germ 0.342778 General information 0.25607 Serum tumor marker 0.272202 treatment 0.407159 new cancer treatments 0.252812 NCI-supported cancer 0.263007 cancer cells 0.297225 Cancer Information Service 0.252834 treatment clinical trials 0.280785 National Cancer Institute 0.29056 tumor cells 0.30292 new treatment 0.320955 primary tumor 0.264969 prognosis group 0.287143 metastatic tumor 0.274305 blood 0.260611 nonseminoma extragonadal germ 0.343285 germ cell tumors 0.795411 cancer clinical trials 0.308911 cancer information summaries 0.252228 comprehensive cancer information 0.25212 cancer 0.522779 standard treatment 0.259689	CLICK HERE
1638	National Cancer Institute	Html	en	Essiac/Flor Essence (PDQ®)–Patient Version	Essiac and Flor Essence are herbal tea mixtures first developed in Canada that are thought to remove toxins and poisons from the body and strengthen the immune system, although this has not been proven in cancer patients. Read about the history of Essiac and Flor Essence, the theory behind its use, and the results of laboratory, animal, and human studies.	Essiac formula 0.502569 peer-reviewed scientific journals 0.490423 cancer treatment 0.454247 cancer prevention 0.375568 Complementary Therapies Editorial 0.416551 Kill cancer cells 0.376017 breast cancer patient 0.382628 Drug Administration 0.400504 Cancer Information Specialist 0.387931 Flor Essence 0.977313 Flor Essence state 0.48205 herbal dietary supplements 0.446297 Flor Essence formulas 0.482148 Cancer Information Service 0.448298 Essiac 0.851494 Essiac herbal teas 0.514938 PDQ cancer information 0.515287 health tonics 0.425459 Cancer Complementary 0.397385 Flor Essence products 0.478002 CAM therapies 0.376991 prostate cancer cells 0.376887 Flor Essence tea 0.479505 National Cancer Institute 0.598699	studies 0.410222 Sloan-Kettering Cancer Center 0.381887 clinical trials 0.491591 Royal Cancer Commission 0.384396 alternative medicine 0.441037 health care 0.376403 cancer information summary 0.466243 alternative cancer therapies 0.394811 Federal Trade Commission 0.379856 clinical trial 0.417042 cancer cells 0.389663 Essiac/Flor Essence 0.431725 CAM cancer research 0.383472 herbal tea mixtures 0.394707 cancer patients 0.424798 NCI PDQ cancer 0.416273 cancer information database 0.392781 effects 0.382227 alternative therapies 0.415163 cancer information summaries 0.394001 Therapies Editorial Board 0.400185 cancer 0.660273 research studies 0.398662	CLICK HERE
1644	National Cancer Institute	Html	en	Gerson Therapy (PDQ®)–Patient Version	Expert-reviewed information summary about the use of the Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	treatment 0.476929 cancer treatment 0.426084 cancer prevention 0.384318 Complementary Therapies Editorial 0.435586 Cancer Information Specialist 0.399657 Drug Administration 0.382514 body 0.378493 Cancer Information Service 0.518118 PDQ cancer information 0.525476 Cancer Complementary 0.410407 CAM therapies 0.388339 Gerson’s therapy 0.456461 treatment clinical trials 0.381128 Gerson therapy reports 0.478587 National Cancer Institute 0.663474 clinical trials 0.562754 Dr. Gerson 0.569329 alternative medicine 0.46145 health care providers 0.421555 health care 0.444706 cancer information summary 0.471527 Max B. Gerson 0.46509 Gerson Research Organization 0.453179 alternative cancer therapies 0.404484	Federal Trade Commission 0.391653 National Institutes 0.385207 clinical trial 0.399404 National Center 0.376357 CAM cancer research 0.391227 new treatment 0.374685 breast cancer prevention 0.381892 patients 0.477683 cancer patients 0.443285 Cancer Care page 0.385186 latest published information 0.376378 key parts 0.39704 NCI’s PDQ 0.381863 PDQ summary 0.408051 Integrative Health 0.376266 NCI PDQ cancer 0.437412 cancer information database 0.407023 alternative therapies 0.430873 cancer information summaries 0.407395 Therapies Editorial Board 0.414248 cancer 0.692284 gerson therapy 0.948648 cancer information 0.545756	CLICK HERE
1732	National Cancer Institute	Html	en	Targeted Cancer Therapies	A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.	targeted therapies 0.916839 traditional chemotherapy drugs 0.434184 cancer vaccines 0.439223 cancer cells 0.924402 new blood vessel 0.443884 leukemic cells 0.432134 angiogenesis inhibitors 0.440608 Targeted cancer therapies 0.81804 fact sheets Cancer 0.457828 cancer cell growth 0.589511 specific cancer cells 0.553642 gene expression modulators 0.438407 pancreatic cancer 0.4493 hormone therapies 0.533362 specific target protein 0.46382 differentially expressed target 0.440917 nci-supported clinical trials 0.437017 molecularly targeted drugs 0.562455 clinical trials 0.591045 tumor cells 0.46028 normal cells 0.520102 targeted therapy 0.645434 specific targeted therapy 0.552585 breast cancer 0.484727	Biological Therapies 0.463149 growth factor receptor 0.473185 cancerous cells 0.44351 cancer development 0.434952 experimental targeted therapies 0.619071 targeted therapy trastuzumab 0.545984 Keytruda®) 0.487223 specific types 0.440167 prostate cancer 0.45274 cancer clinical trials 0.499699 tumor cell proliferation 0.433817 certain cancer types 0.465459 high blood pressure 0.438907 metastatic breast cancer 0.450488 particular targeted therapy 0.540161 epidermal growth factor 0.475814 specific molecular targets 0.438616 signal transduction inhibitors 0.526574 potential targets 0.462585 certain immune cells 0.461941 (Rituxan Hycela™) 0.432805 different targeted therapies 0.660128 monoclonal antibodies 0.565531	CLICK HERE
1802	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin en adultos.	after treatment 0.32907 hodgkin's disease 0.974381 risk after 0.31263 lymphocyte predominant hodgkin 0.318894 prognostic factors 0.314973 limited stage hodgkin 0.313655 early-stage hodgkin 0.357479 following hodgkin 0.342696 Lymphoma Study Group 0.312404 Hodgkin's Study 0.313145 lymphocyte-predominant hodgkin 0.411856 Radiat Oncol Biol 0.313583 Hodgkin lymphoma patients 0.316654 Natl Cancer Inst 0.33424 lymphocyte-predominant hodgkin disease 0.363459 survivors after hodgkin 0.311932 from hodgkin 0.320125 lymphoma treated with 0.313078 patients with 0.322542 risk following hodgkin 0.312032 leukemia following hodgkin 0.320131 hodgkin's lymphoma 0.767848 lymphocyte-rich classical hodgkin 0.31922 Hodgkin's lymphoma treated 0.328493 Hodgkin Lymphoma study 0.318752	ia lymphocyte-predominant hodgkin 0.311912 german hodgkin study 0.412479 after hodgkin 0.345197 nodular lymphocyte-predominant hodgkin 0.337091 hodgkin study group 0.386928 with hodgkin 0.364083 early stage hodgkin 0.311698 advanced hodgkin 0.325939 Hodgkin's Disease Staging 0.316019 with classical hodgkin 0.313045 advanced hodgkin disease 0.325216 EORTC Lymphoma 0.311774 elderly hodgkin 0.312531 Clin Oncol 0.703258 German Hodgkin Lymphoma 0.326196 patients treated 0.312778 Oncol Biol Phys 0.313852 Hodgkin lymphoma treated 0.316446 hodgkin lymphoma 0.74467 lymphocyte-predominant hodgkin lymphoma 0.4086 Hodgkin's Disease Cancer 0.321788 classical hodgkin lymphoma 0.356483 cancer risk 0.335147 lymphocyte-depleted classical hodgkin 0.313017	CLICK HERE
2111	National Cancer Institute	Html	es	Exámenes de detección del cáncer de esófago (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de esófago.	PDQ Exámenes 0.728989 Physician Data Query 0.906997 libre uso 0.636785 prevención revisa 0.652274 información ayuda 0.682663 vías respiratorias 0.673206	carcinoma epidermoide 0.760269 National Cancer Institute 0.66546 cáncer.ampliar esofagoscopía 0.714851 siguientes riesgos 0.649549 siguientes sumarios 0.849506 Instituto Nacional 0.740034	CLICK HERE